Phoenix Bio



Results from Studies using PXB-Mouse being presented at EASL 2017

April 14, 2017

There will be poster presentations featuring PXB-mice at EASL The International Liver Congress 2017.  The Meeting will be held in Amsterdam,  The Netherlands from April 19th to April 23rd.

Poster Presentation

Presentation Date:April, 20, 2017 (Thu.)

Presentation Number:THU-164

Title:Superior suppression of hepatitis B virus DNA and antigen levels in a chimeric mouse model when BB-103, a DNA-directed RNA interference agent, is coupled with standard of care drugs

Presenter:Dr. David Suhy (Benitec Biopharma)

Presentation Date:April, 21, 2017 (Fri.)

Presentation Number:FRI-152

Title:No changes in the coding sequence for HBV core protein after 6 weeks of treatment of HBV infected humanized mice with NVR 3-778

Presenter:Dr. Angela Lam (Novira Therapeutics)

Presentation Date:April, 22, 2017 (Sat.)

Presentation Number:SAT-363

Title:Activation of FXR by steroidal or non-steroidal agonists causes an increase in LDL-cholesterol in mice with humanized chimeric liver

Presenter:Dr. Mark Young (Intercept Pharmaceuticals, Inc.)

Commercial Booth

Booth # 77

Our booth will be located in Exhibition Area.

Exhibit Hours

Apr. 20 (Thu.)   9:30 – 16:30

Apr. 21 (Fri.)    9:30 – 16:30

Apr. 22 (Sat.)  9:30 – 16:30